Nothing like kicking off a convention with a press conference called "Sexy Sex Findings."
Aksam Yassin, MD, briefed reporters on a study that suggests internists should look carefully at male patients who show up in their office complaining of ED. These patients often have testosterone deficiency, diabetes, high BP and/or dyslipidemia, his study found, yet many of the patients are unaware of their problems. ED can thus be the gateway to finding and treating these issues, said Dr. Yassin, who is from the Clinic for Urology and Andrology of the Segeberger Clinics in Norderstedt, Germany.
And now a little something for the ladies, as they say. Michael Snabes, MD, VP of clinical development at BioSante Pharmaceuticals, spoke about a planned study to test LibiGel, a testosterone treatment for low sexual desire in menopausal women. (Libido + Gel. Get it?) The study is examining CV and breast effects. If all goes well, the gel is expected to be available in 2011 for women age 50+ years. Mr. Snabes declined my offer to speculate on how much it might cost.